Eloxx Pharmaceuticals Inc (ELOX)
0.90
+0.05
(+5.88%)
USD |
OTCM |
May 03, 15:44
Eloxx Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.2833 |
| September 30, 2013 | 1.033 |
| June 30, 2013 | 0.5777 |
| March 31, 2013 | 0.6605 |
| December 31, 2012 | 1.391 |
| September 30, 2012 | 0.8363 |
| June 30, 2012 | 0.6369 |
| March 31, 2012 | 0.4782 |
| December 31, 2011 | 0.7762 |
| September 30, 2011 | 0.5591 |
| June 30, 2011 | 0.4868 |
| March 31, 2011 | 0.3181 |
| December 31, 2010 | 0.3267 |
| September 30, 2010 | 0.3182 |
| June 30, 2010 | 0.275 |
| March 31, 2010 | 13.12 |
| December 31, 2009 | 0.0361 |
| Date | Value |
|---|---|
| September 30, 2009 | 0.0251 |
| June 30, 2009 | 0.0011 |
| March 31, 2009 | 0.0148 |
| December 31, 2008 | 0.0128 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.1212 |
| December 31, 2007 | 0.032 |
| September 30, 2007 | 0.0033 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| September 30, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| March 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| September 30, 2004 | 0.00 |
| June 30, 2004 | 0.00 |
| March 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| September 30, 2003 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.042M |
| Total Liabilities (Quarterly) | 26.09M |
| Shareholders Equity (Quarterly) | -20.05M |